Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
OGN | Organon & Co. | Head of R&D & CMO | $500 K | Mar 29, 2024 | ||
MYOV | Myovant Sciences Ltd. | Chief Medical Officer | Mar 10, 2023 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|